Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of $111.44 billion. The enterprise value is $119.85 billion.
Important Dates
The next confirmed earnings date is Friday, October 24, 2025, before market open.
| Earnings Date | Oct 24, 2025 |
| Ex-Dividend Date | May 9, 2025 |
Share Statistics
Sanofi has 1.22 billion shares outstanding. The number of shares has decreased by -0.92% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.22B |
| Shares Change (YoY) | -0.92% |
| Shares Change (QoQ) | -1.36% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 58.75% |
| Float | 1.10B |
Valuation Ratios
The trailing PE ratio is 10.40 and the forward PE ratio is 9.64.
| PE Ratio | 10.40 |
| Forward PE | 9.64 |
| PS Ratio | 2.07 |
| Forward PS | 2.42 |
| PB Ratio | 1.35 |
| P/TBV Ratio | 5.47 |
| P/FCF Ratio | 10.00 |
| P/OCF Ratio | 8.46 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 8.45, with an EV/FCF ratio of 10.76.
| EV / Earnings | 11.18 |
| EV / Sales | 2.23 |
| EV / EBITDA | 8.45 |
| EV / EBIT | 10.88 |
| EV / FCF | 10.76 |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.32.
| Current Ratio | 1.27 |
| Quick Ratio | 0.81 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 1.80 |
| Debt / FCF | 2.35 |
| Interest Coverage | 16.91 |
Financial Efficiency
Return on equity (ROE) is 9.00% and return on invested capital (ROIC) is 6.20%.
| Return on Equity (ROE) | 9.00% |
| Return on Assets (ROA) | 4.60% |
| Return on Invested Capital (ROIC) | 6.20% |
| Return on Capital Employed (ROCE) | 9.78% |
| Revenue Per Employee | $648,117 |
| Profits Per Employee | $129,317 |
| Employee Count | 82,878 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.30 |
Taxes
In the past 12 months, Sanofi has paid $1.80 billion in taxes.
| Income Tax | 1.80B |
| Effective Tax Rate | 19.24% |
Stock Price Statistics
The stock price has decreased by -19.61% in the last 52 weeks. The beta is 0.44, so Sanofi's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | -19.61% |
| 50-Day Moving Average | 48.24 |
| 200-Day Moving Average | 50.89 |
| Relative Strength Index (RSI) | 37.73 |
| Average Volume (20 Days) | 3,878,061 |
Short Selling Information
The latest short interest is 4.93 million, so 0.41% of the outstanding shares have been sold short.
| Short Interest | 4.93M |
| Short Previous Month | 5.03M |
| Short % of Shares Out | 0.41% |
| Short % of Float | 0.45% |
| Short Ratio (days to cover) | 1.78 |
Income Statement
In the last 12 months, Sanofi had revenue of $53.71 billion and earned $10.72 billion in profits. Earnings per share was $8.65.
| Revenue | 53.71B |
| Gross Profit | 38.31B |
| Operating Income | 11.02B |
| Pretax Income | 9.38B |
| Net Income | 10.72B |
| EBITDA | 14.19B |
| EBIT | 11.02B |
| Earnings Per Share (EPS) | $8.65 |
Full Income StatementBalance Sheet
The company has $18.04 billion in cash and $26.17 billion in debt, giving a net cash position of -$8.13 billion or -$6.68 per share.
| Cash & Cash Equivalents | 18.04B |
| Total Debt | 26.17B |
| Net Cash | -8.13B |
| Net Cash Per Share | -$6.68 |
| Equity (Book Value) | 82.54B |
| Book Value Per Share | 67.55 |
| Working Capital | 9.35B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $13.17 billion and capital expenditures -$1.99 billion, giving a free cash flow of $11.14 billion.
| Operating Cash Flow | 13.17B |
| Capital Expenditures | -1.99B |
| Free Cash Flow | 11.14B |
| FCF Per Share | $9.15 |
Full Cash Flow StatementMargins
Gross margin is 71.32%, with operating and profit margins of 20.51% and 19.95%.
| Gross Margin | 71.32% |
| Operating Margin | 20.51% |
| Pretax Margin | 17.46% |
| Profit Margin | 19.95% |
| EBITDA Margin | 26.42% |
| EBIT Margin | 20.51% |
| FCF Margin | 20.74% |
Dividends & Yields
This stock pays an annual dividend of $1.60, which amounts to a dividend yield of 3.51%.
| Dividend Per Share | $1.60 |
| Dividend Yield | 3.51% |
| Dividend Growth (YoY) | 8.13% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 18.49% |
| Buyback Yield | 0.92% |
| Shareholder Yield | 4.43% |
| Earnings Yield | 9.62% |
| FCF Yield | 10.00% |
Dividend DetailsAnalyst Forecast
The average price target for Sanofi is $61.50, which is 35.05% higher than the current price. The consensus rating is "Buy".
| Price Target | $61.50 |
| Price Target Difference | 35.05% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 4.41% |
| EPS Growth Forecast (5Y) | 18.73% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |